Medical breakthrough
The treatment was developed by Eli Lilly & Company and is proven to slow cognitive decline by 30%, according to press release by the Alzheimer's Drug Discovery Foundation.
Your privacy choices
Allow Google Analytics to help us understand which pages readers visit? It uses cookies only if you choose Allow. Cookie policy